Treatment of keloids and hypertrophic scars. Position statement of the Brazilian expert group GREMCIQ
Gisele Viana de Oliveira, Leandra d’Orsi Metsavaht, Bogdana Victória Kadunc, S.K.K. Jedwab, Maddalena Bressan, Hamílton Ometto Stolf, Rubén García Castro, SARITA M.F.M.C. BEZERRA, D.A. Calil, F.A.Z. Addor, José Carlos Soares de Fraga, Carmélia Matos Santiago Reis, Eugenio Galdino de Mendonça Reis-Filho, Márcio Roberto Silva, Márcia Ramos‐e‐Silva, Dóris Hexsel
Abstract
Keloids (K) and hypertrophic scars (HS) are abnormal responses to wound healing that occur as the result of dermal inflammation. Despite the advances on their treatment, many patients still suffer from the negative effects of excessive scarring; its approach is impaired by the lack of objective data on different treatments and the large genetic variability among patients and the difficulties in producing multicentre studies. Their incidence among the Brazilian population is high, as the result of an admixture of Amerindians, Europeans and Africans ancestral roots. With the aim of producing multicentre studies on K and HS, a panel of senior Brazilian dermatologists focused on their treatment was invited to contribute with the K and HS Treatment Brazilian Guidelines. In the first part of this study, different treatment modalities for keloids and HS are fully reviewed by the panel. The second part of the study presents a consensus recommendation of treatment for different types of lesions. More than a literature review, this article aims to show the pitfalls and pearls of each therapeutic option, as well as a therapeutic approach by the Panel of Experts on keloids and Scars on a highly mixed population, providing simple guidelines.